Results 21 to 30 of about 31,185 (231)

Association of Serum Ammonia Levels with Severity of Grades of Hepatic Encephalopathy in Patients Presenting to er of a Tertiary Care Hospital

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To determine the association of serum Ammonia levels with severity of grades of hepatic encephalopathy in patients presenting to the department. Study Design: Comparative cross-sectional study.
Muhammad Dawood   +5 more
doaj   +1 more source

Hepatic Encephalopathy [PDF]

open access: yesVeterinary Clinics of North America: Small Animal Practice, 2017
This article reviews hepatic encephalopathy (HE) in companion animals. Clinical signs and categories of hepatic disease likely to cause HE are discussed. Ammonia has a key role in pathogenesis and current concepts in body ammonia metabolism are reviewed. Inflammation and manganese accumulation are also thought to be important in pathogenesis. Treatment
openaire   +6 more sources

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

open access: yesHepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman   +4 more
wiley   +1 more source

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran   +17 more
wiley   +1 more source

Neuroinflammatory Signals during Acute and Chronic Liver Diseases [PDF]

open access: yes, 2017
A spectrum of neurological complications can result from acute and chronic liver diseases and is termed hepatic encephalopathy. The precise pathogenic mechanisms by which hepatic encephalopathy occurs is unclear. However, it is commonly accepted that the
DeMorrow, Sharon, McMillin, Matthew
core   +1 more source

A Challenging Case of Refractory Hepatic Encephalopathy in a Postliver Retransplant Patient with Thrombosed Portal Vein: A Shunt for a Shunt

open access: yesCase Reports in Hepatology, 2023
Hepatic encephalopathy (HE) is a frequent and serious complication of chronic liver disease. The mechanism of hepatic encephalopathy is not entirely clear. Hepatic encephalopathy is defined as brain dysfunction caused by liver insufficiency and/or portal-
Fady Salama   +3 more
doaj   +1 more source

Neonatal EEG graded for severity of background abnormalities in hypoxic-ischaemic encephalopathy [PDF]

open access: yesSci Data 10, 129 (2023), 2022
This report describes a set of neonatal electroencephalogram (EEG) recordings graded according to the severity of abnormalities in the background pattern. The dataset consists of 169 hours of multichannel EEG from 53 neonates recorded in a neonatal intensive care unit.
arxiv   +1 more source

Rifaximin Treatment in Hepatic Encephalopathy [PDF]

open access: yes, 2010
Background Hepatic encephalopathy is a chronically debilitating complication of hepatic cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the treatment of acute hepatic encephalopathy, but its efficacy for ...
Bass, Nathan M.   +16 more
core   +2 more sources

Prevalence of minimal hepatic encephalopathy among patients with chronic liver disease in Ilorin, Nigeria [PDF]

open access: yes, 2020
Background: Minimal Hepatic encephalopathy is the mildest form of Hepatic Encephalopathy which presents with significant cognitive impairment and affectation of activities of daily living.
Akintayo, Richard O.   +4 more
core   +2 more sources

Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open‐Label, Single‐Dose, Parallel Group Study

open access: yesThe Journal of Clinical Pharmacology, Volume 63, Issue 2, Page 250-258, February 2023., 2023
Abstract Maribavir, an orally bioavailable antiviral, has shown superior activity against posttransplant cytomegalovirus infection compared with conventional antivirals. It is primarily metabolized in the liver. This open‐label, single‐center study evaluated the effect of hepatic impairment on the pharmacokinetics of maribavir in nontransplant ...
Ivy Song   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy